Tumour regression in the randomized Stockholm III Trial of radiotherapy regimens for rectal cancer

D Pettersson, E Lörinc, T Holm, H Iversen, B Cedermark, B Glimelius, A Martling, D Pettersson, E Lörinc, T Holm, H Iversen, B Cedermark, B Glimelius, A Martling

Abstract

Background: The Stockholm III Trial randomized patients with primary operable rectal cancers to either short-course radiotherapy (RT) with immediate surgery (SRT), short-course RT with surgery delayed 4-8 weeks (SRT-delay) or long-course RT with surgery delayed 4-8 weeks. This preplanned interim analysis examined the pathological outcome of delaying surgery.

Methods: Patients randomized to the SRT and SRT-delay arms in the Stockholm III Trial between October 1998 and November 2010 were included, and data were collected in a prospective register. Additional data regarding tumour regression grade, according to Dworak, and circumferential margin were obtained by reassessment of histopathological slides.

Results: A total of 462 of 545 randomized patients had specimens available for reassessment. Patients randomized to SRT-delay had earlier ypT categories, and a higher rate of pathological complete responses (11·8 versus 1·7 per cent; P = 0·001) and Dworak grade 4 tumour regression (10·1 versus 1·7 per cent; P < 0·001) than patients randomized to SRT without delay. Positive circumferential resection margins were uncommon (6·3 per cent) and rates did not differ between the two treatment arms.

Conclusion: Short-course RT induces tumour downstaging if surgery is performed after an interval of 4-8 weeks.

© 2015 The Authors. BJS published by John Wiley & Sons Ltd on behalf of BJS Society Ltd.

Figures

Figure 1
Figure 1
Flow diagram of randomization to the Stockholm III Trial, and patient selection to the present study of the trial arms with short‐course radiotherapy (RT) with immediate surgery (SRT) and short‐course RT with surgery delayed 4–8 weeks (SRT‐delay). The trial arm with long‐course RT and surgery delayed 4–8 weeks (LRT‐delay) was not analysed in the present study

References

    1. Peeters KC, Marijnen CA, Nagtegaal ID, Kranenbarg EK, Putter H, Wiggers T et al The TME trial after a median follow‐up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma. Ann Surg 2007; 246: 693–701.
    1. Kapiteijn E, Marijnen CA, Nagtegaal ID, Putter H, Steup WH, Wiggers T et al Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 2001; 345: 638–646.
    1. Pahlman L, Glimelius B. Pre‐ or postoperative radiotherapy in rectal and rectosigmoid carcinoma. Report from a randomized multicenter trial. Ann Surg 1990; 211: 187–195.
    1. Improved survival with preoperative radiotherapy in resectable rectal cancer. Swedish Rectal Cancer Trial [see comments]. N Engl J Med 1997; 336: 980–987
    2. [published erratum appears in N Engl J Med 1997; 336: 1539].
    1. Martling A, Holm T, Johansson H, Rutqvist L, Cedermark B. The Stockholm II trial on preoperative radiotherapy in rectal carcinoma. Cancer 2001; 92: 896–902.
    1. Cedermark B, Johansson H, Rutqvist LE, Wilking N. The Stockholm I trial of preoperative short term radiotherapy in operable rectal carcinoma. A prospective randomized trial. Stockholm Colorectal Cancer Study Group. Cancer 1995; 75: 2269–2275.
    1. Colorectal Cancer Collaborative Group . Adjuvant radiotherapy for rectal cancer: a systematic overview of 8507 patients from 22 randomised trials. Lancet 2001; 358: 1291–1304.
    1. Glimelius B, Grönberg H, Järhult J, Wallgren A, Cavallin‐Ståhl E. A systematic overview of radiation therapy effects in rectal cancer. Acta Oncol 2003; 42: 476–492.
    1. Bujko K, Nowacki MP, Nasierowska‐Guttmejer A, Michalski W, Bebenek M, Pudelko M et al Sphincter preservation following preoperative radiotherapy for rectal cancer: report of a randomised trial comparing short‐term radiotherapy vs. conventionally fractionated radiochemotherapy. Radiother Oncol 2004; 72: 15–24.
    1. Glimelius B, Holm T, Blomqvist L. Chemotherapy in addition to preoperative radiotherapy in locally advanced rectal cancer – a systematic overview. Rev Recent Clin Trials 2008; 3: 204–211.
    1. Marijnen CA, Nagtegaal ID, Klein Kranenbarg E, Hermans J, van de Velde CJ, Leer JW et al No downstaging after short‐term preoperative radiotherapy in rectal cancer patients. J Clin Oncol 2001; 19: 1976–1984.
    1. Sebag‐Montefiore D, Stephens RJ, Steele R, Monson J, Grieve R, Khanna S et al Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC‐CTG C016): a multicentre, randomised trial. Lancet 2009; 373: 811–820.
    1. Hatfield P, Hingorani M, Radhakrishna G, Cooper R, Melcher A, Crellin A et al Short‐course radiotherapy, with elective delay prior to surgery, in patients with unresectable rectal cancer who have poor performance status or significant co‐morbidity. Radiother Oncol 2009; 92: 210–214.
    1. Radu C, Berglund A, Pâhlman L, Glimelius B. Short‐course preoperative radiotherapy with delayed surgery in rectal cancer – a retrospective study. Radiother Oncol 2008; 87: 343–349.
    1. Pettersson D, Holm T, Iversen H, Blomqvist L, Glimelius B, Martling A. Preoperative short‐course radiotherapy with delayed surgery in primary rectal cancer. Br J Surg 2012; 99: 577–583.
    1. Pach R, Kulig J, Richter P, Gach T, Szura M, Kowalska T. Randomized clinical trial on preoperative radiotherapy 25 Gy in rectal cancer – treatment results at 5‐year follow‐up. Langenbecks Arch Surg 2012; 397: 801–807.
    1. Pettersson D, Cedermark B, Holm T, Radu C, Pâhlman L, Glimelius B et al Interim analysis of the Stockholm III trial of preoperative radiotherapy regimens for rectal cancer. Br J Surg 2010; 97: 580–587.
    1. Fokstuen T, Holm T, Glimelius B. Postoperative morbidity and mortality in relation to leukocyte counts and time to surgery after short‐course preoperative radiotherapy for rectal cancer. Radiother Oncol 2009; 93: 293–297.
    1. Jörgren F, Johansson R, Damber L, Lindmark G. Validity of the Swedish Rectal Cancer Registry for patients treated with major abdominal surgery between 1995 and 1997. Acta Oncol 2013; 52: 1707–1714.
    1. Sobin LH, Wittekind C. International Union Against Cancer TNM Classification of Malignant Tumours (6th edn). John Wiley & Sons: New York, 2002.
    1. Greene FL, Flemming ID, Fritz A, Balch CM, Haller DG, Morrow M. (eds). AJCC Cancer Staging Manual (6th edn). Springer: New York, 2002.
    1. Dworak O, Keilholz L, Hoffmann A. Pathological features of rectal cancer after preoperative radiochemotherapy. Int J Colorectal Dis 1997; 12: 19–23.
    1. Graf W, Dahlberg M, Osman MM, Holmberg L, Pahlman L, Glimelius B. Short‐term preoperative radiotherapy results in down‐staging of rectal cancer: a study of 1316 patients. Radiother Oncol 1997; 43: 133–137.
    1. Glimelius B, Beets‐Tan R, Blomqvist L, Brown G, Nagtegaal I, Pahlman L et al Mesorectal fascia instead of circumferential resection margin in preoperative staging of rectal cancer. J Clin Oncol 2011; 29: 2142–2143.
    1. Maas M, Nelemans PJ, Valentini V, Das P, Rödel C, Kuo L‐J et al Long‐term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data. Lancet Oncol 2010; 11: 835–844.
    1. Rödel C, Martus P, Papadoupolos T, Füzesi L, Klimpfinger M, Fietkau R et al Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer. J Clin Oncol 2005; 23: 8688–8696.
    1. Gerard JP, Conroy T, Bonnetain F, Bouche O, Chapet O, Closon‐Dejardin MT et al Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3–4 rectal cancers: results of FFCD 9203. J Clin Oncol 2006; 24: 4620–4625.
    1. Bosset J‐F, Calais G, Mineur L, Maingon P, Stojanovic‐Rundic S, Bensadoun R‐J et al Fluorouracil‐based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long‐term results of the EORTC 22921 randomised study. Lancet Oncol 2014;15: 184–190.
    1. Bujko K, Nowacki MP, Nasierowska‐Guttmejer A, Michalski W, Bebenek M, Kryj M. Long‐term results of a randomized trial comparing preoperative short‐course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer. Br J Surg 2006; 93: 1215–1223.
    1. Bujko K, Bujko M. Point: short‐course radiation therapy is preferable in the neoadjuvant treatment of rectal cancer. Semin Radiat Oncol 2011; 21: 220–227.
    1. Valentini V, Aristei C, Glimelius B, Minsky BD, Beets‐Tan R, Borras JM et al Multidisciplinary Rectal Cancer Management: 2nd European Rectal Cancer Consensus Conference (EURECA‐CC2). Radiother Oncol 2009; 92: 148–163.
    1. Glimelius B, Tiret E, Cervantes A, Arnold D; ESMO Guidelines Working Group . Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow‐up. Ann Oncol 2013; 24(Suppl 6): vi81–vi88.

Source: PubMed

스폰서 및 공동 작업자

건강 상태

약물 개입

3
구독하다